Work

Pos0528 Patient Experiences With Chronic Refractory Gout and Its Impact on Health-related Quality of Life

Year: 2023

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2023-eular.1389

Authors: A. Oladapo, V. Strand, N. Kragh, N. Johnson, C. Yousefian, D. Brooks, H. Sharp, C. Kim, M. Pillinger

Institutions: Stanford University, Swedish Orphan Biovitrum (Sweden), New York University

Language: English

Topic: Gout, Hyperuricemia, Uric Acid

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Gilead Sciences, Regeneron Pharmaceuticals, Kiniksa Pharmaceuticals, Harmony Biosciences, Celltrion, Omeros Corporation, Horizon Therapeutics, Swedish Orphan Biovitrum, Genentech, Samsung, UCB Pharma

OpenAlex ID: W4379517678

Cites:

Cited by:

Related to: 9